| Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery (NCT02234297) | Blaze Bioscience Inc. | 2014-10-01 |
| Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma (NCT03843814) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-08-01 |
| Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide (NCT01450826) | Katy Peters | 2014-06-24 |
| 68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients (NCT02327442) | Xijing Hospital | 2014-06-01 |
| Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic Gliomas (NCT02115074) | Centre Oscar Lambret | 2014-06-01 |
| Open-Label Study of I-131-CLR1404 in Subjects With Recurrent Glioma (NCT01778088) | Cellectar Biosciences, Inc. | 2014-05-01 |
| Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma (NCT02176720) | The Methodist Hospital Research Institute | 2014-05-01 |
| Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (NCT02029690) | Polaris Group | 2014-04-23 |
| Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas (NCT01986348) | Karyopharm Therapeutics Inc | 2014-03-03 |
| Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation (NCT02073994) | Institut de Recherches Internationales Servier | 2014-03-01 |
| Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors (NCT02052648) | NewLink Genetics Corporation | 2014-03-01 |
| Improving Ultrasound Images in Brain Tumor Surgery With the Use of Brain Mimicking Fluid (NCT02105233) | St. Olavs Hospital | 2014-02-01 |
| 5-ALA in Recurrent Glioma (NCT02119338) | St. Joseph's Hospital and Medical Center, Phoenix | 2014-02-01 |
| Study of the Anti-tumoral Immune Response (NCT02854644) | Centre Hospitalier Universitaire de Besancon | 2014-01-27 |
| Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma (NCT02010606) | Cedars-Sinai Medical Center | 2014-01-08 |
| Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial (NCT03082846) | Xue Xiaoying | 2014-01-01 |
| Spinal Motor Evoked Potentials in Brain Surgery (NCT02402075) | Heinrich-Heine University, Duesseldorf | 2014-01-01 |
| Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET) (NCT02022800) | Centre Antoine Lacassagne | 2013-11-01 |
| ANG1005 in Patients With Recurrent High-Grade Glioma (NCT01967810) | Angiochem Inc | 2013-10-01 |
| Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors (NCT01902771) | Edward Ziga | 2013-09-03 |
| Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases (NCT07379463) | Tianjin Medical University | 2013-08-29 |
| Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 (NCT02122822) | Cure&Sure Biotech Co., LTD | 2013-07-01 |
| Hypofractionated IMRT With Temozolomide for HGG (NCT02082119) | Istituto Clinico Humanitas | 2013-07-01 |
| Valproic Acid in Childhood Progressive Brain Tumors (NCT01861990) | Medical University of South Carolina | 2013-05-01 |
| Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors (NCT01999270) | Washington University School of Medicine | 2013-04-01 |
| Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia (NCT02363075) | Assistance Publique - Hôpitaux de Paris | 2013-04-01 |
| Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery (NCT01798771) | Johann Wolfgang Goethe University Hospital | 2013-03-01 |
| Autologous Natural Killer T Cells Infusion for the Treatment of Cancer (NCT01801852) | Chinese PLA General Hospital | 2013-01-01 |
| A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab (NCT01743950) | University of Wisconsin, Madison | 2012-12-03 |
| Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors (NCT01661400) | Washington University School of Medicine | 2012-10-26 |
| 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma (NCT01801371) | Peking Union Medical College Hospital | 2012-10-01 |
| Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients (NCT01836536) | Center Eugene Marquis | 2012-09-01 |
| Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas (NCT01502605) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-09-01 |
| Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma (NCT01813877) | Jonsson Comprehensive Cancer Center | 2012-08-22 |
| Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction (NCT01638533) | National Cancer Institute (NCI) | 2012-08-03 |
| Isolation and Characterization of Cancer Stem Cells Using iFP Technique (NCT01641003) | Rambam Health Care Campus | 2012-07-01 |
| PVSRIPO for Recurrent Glioblastoma (GBM) (NCT01491893) | Istari Oncology, Inc. | 2012-04-25 |
| Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients (NCT01579253) | Ludwig-Maximilians - University of Munich | 2012-04-01 |
| Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases (NCT02279992) | Cedars-Sinai Medical Center | 2012-03-27 |
| Study of DC Vaccination Against Glioblastoma (NCT01567202) | Huashan Hospital | 2012-03-01 |
| Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program (NCT01772771) | M.D. Anderson Cancer Center | 2012-03-01 |
| Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma (NCT02481960) | Boston Scientific Corporation | 2012-02-21 |
| Quality of Life and Patient Needs in Advanced High Grade Gliomas (NCT05039346) | Henry Ford Health System | 2012-02-11 |
| MicroRNAs in Patients With Neurofibromatosis Type 1 (NCT01595139) | Ann & Robert H Lurie Children's Hospital of Chicago | 2012-02-01 |
| Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma (NCT01465347) | Diffusion Pharmaceuticals Inc | 2012-02-01 |
| MRS and 11C-methionine PET/CT in the Diagnosis of Glioma (NCT03009318) | Huashan Hospital | 2012-01-01 |
| Does Notch Regulate Glioma Proliferation ? (NCT04809597) | University Hospital, Montpellier | 2012-01-01 |
| Study of Intraparenchymal Therapy as Adjunct Therapy in Patients With Recurrent, Resectable Glioblastoma Multiforme. (NCT02433392) | Boston Scientific Corporation | 2011-12-01 |
| Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT (NCT01460706) | Turku University Hospital | 2011-10-01 |
| Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma (NCT01478178) | Kintara Therapeutics, Inc. | 2011-10-01 |
| iMRI Guided Resection in Cerebral Glioma Surgery (NCT01479686) | Huashan Hospital | 2011-09-01 |
| A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors (NCT01351519) | MultiCare Health System Research Institute | 2011-05-01 |
| A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma (NCT01220271) | Eli Lilly and Company | 2011-04-01 |
| ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors (NCT01473485) | InSightec | 2011-04-01 |
| Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors (NCT01331135) | Emory University | 2011-04-01 |
| Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas (NCT01229644) | Arog Pharmaceuticals, Inc. | 2011-04-01 |
| Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides (NCT01598454) | Laboratorio Elea Phoenix S.A. | 2011-02-01 |
| A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB (NCT01125800) | Novartis Pharmaceuticals | 2011-02-01 |
| Gene Expression, Immunological Status and Metabolome in Glioma Patients (NCT01525459) | National Institute of Biology, Slovenia | 2010-12-01 |
| Carbon Ion Radiotherapy for Recurrent Gliomas (NCT01166308) | University Hospital Heidelberg | 2010-12-01 |
| Fluorescence-guided Surgery for Low- and High-grade Gliomas (NCT01502280) | St. Joseph's Hospital and Medical Center, Phoenix | 2010-11-01 |
| Dendritic Cell Vaccine for Patients With Brain Tumors (NCT01204684) | Jonsson Comprehensive Cancer Center | 2010-10-08 |
| A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain (NCT01403311) | Legacy Health System | 2010-10-01 |
| Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study (NCT01212731) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain (NCT01116661) | University of California, San Francisco | 2010-08-01 |
| A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors (NCT01182883) | National Cancer Institute (NCI) | 2010-07-28 |
| Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas (NCT01140568) | David Piccioni, M.D., Ph.D | 2010-04-21 |
| Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma (NCT01081223) | TVAX Biomedical | 2010-04-01 |
| MR Textural Analysis in Low Grade Gliomas (NCT04719806) | Centre Hospitalier Universitaire de Nice | 2010-01-01 |
| Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma (NCT00979173) | Annick Desjardins | 2009-11-01 |
| Image-Guided Stereotactic Biopsy of High Grade Gliomas (NCT00979810) | Memorial Sloan Kettering Cancer Center | 2009-09-16 |
| Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients (NCT00985036) | Marquette General Health System | 2009-09-01 |
| Comparison of Neuro-navigational Systems for Resection-Control of Brain Tumors (NCT00977327) | Tel-Aviv Sourasky Medical Center | 2009-09-01 |
| A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma (NCT01044966) | Medical University of South Carolina | 2009-09-01 |
| Image Guided Therapy in the Treatment of Gliomas (NCT01263821) | NYU Langone Health | 2009-08-01 |
| Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma (NCT00734864) | Annick Desjardins | 2009-06-01 |
| Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer (NCT00909558) | Envita Medical Center, Inc. | 2009-05-01 |
| An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma (NCT00880061) | National Institute of Neurological Disorders and Stroke (NINDS) | 2009-04-07 |
| A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma (NCT01020292) | Abramson Cancer Center at Penn Medicine | 2009-04-01 |
| Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors (NCT00870129) | Memorial Sloan Kettering Cancer Center | 2009-03-01 |
| Development of Magnetic Resonance Spectroscopy (MRS) Biomarkers of Tumor Metabolism (MK-0000-145) (NCT01138813) | Merck Sharp & Dohme LLC | 2009-03-01 |
| Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using Multi-exponential T2 Components (NCT00813787) | AHS Cancer Control Alberta | 2009-02-01 |
| Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas (NCT00795457) | Ian F. Pollack, M.D. | 2009-01-01 |
| Coping With High Grade Glioma (NCT00815152) | Duke University | 2008-12-01 |
| BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma (NCT00727506) | Boehringer Ingelheim | 2008-07-14 |
| Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor (NCT00694330) | Massachusetts General Hospital | 2008-06-01 |
| Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma (NCT00795665) | University of California, Davis | 2008-06-01 |
| A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma (NCT00660621) | Kentuckiana Cancer Institute | 2008-04-01 |
| Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs) (NCT00575796) | The Hospital for Sick Children | 2007-10-01 |
| Comparative Study of Intraoperative MRI-guided vs. Conventional Glioma Surgery (NCT01394692) | Goethe University | 2007-10-01 |
| A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas (NCT00532948) | Hoffmann-La Roche | 2007-05-01 |
| Combination of Irinotecan and Temozolomide in Children With Brain Tumors. (NCT00404495) | Pfizer | 2007-04-01 |
| Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy (NCT00454935) | Amsterdam UMC, location VUmc | 2007-04-01 |
| Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy (NCT00463203) | Rigshospitalet, Denmark | 2007-03-01 |
| Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer (NCT00045968) | Northwest Biotherapeutics | 2006-12-01 |
| Pazopanib In Combination With Lapatinib In Adult Patients With Relapsed Malignant Glioma (NCT00350727) | GlaxoSmithKline | 2006-12-01 |
| Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma (NCT00409214) | Light Sciences Oncology | 2006-11-01 |
| Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes (NCT05635435) | Sun Yat-sen University | 2006-10-13 |
| A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma (NCT00389090) | Keryx / AOI Pharmaceuticals, Inc. | 2006-10-01 |
| Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed) (NCT00424554) | Merck Sharp & Dohme LLC | 2006-09-26 |